BioXcel LLC - Jun 25, 2021 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
10%+ Owner
Signature
/s/ Krishnan Nandabalan, President
Stock symbol
BTAI
Transactions as of
Jun 25, 2021
Transactions value $
-$14,589,493
Form type
4
Date filed
6/29/2021, 05:22 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTAI Common Stock Sale -$14.6M -473K -5.25% $30.83 8.55M Jun 25, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 25, 2021, the Reporting Person sold 473,250 shares of common stock of the Issuer as a selling stockholder in an underwritten public secondary offering at a price to the public of $31.70 per share . The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters after underwriting discounts and commissions.